B7-H1 signaling is integrated during CD8 super(+) T cell priming and restrains effector differentiation
A promising strategy in tumor immunotherapy is the use of activated dendritic cells as vehicles for tumor vaccines with the goal of activating anti-tumor T cell responses. Current formulations for dendritic cell-based immunotherapies have limited effects on patient survival, providing motivation for...
Saved in:
Published in | Cancer Immunology, Immunotherapy Vol. 63; no. 8; pp. 859 - 867 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
01.08.2014
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!